The major side effects of donepezil are gastrointestinal problems, particularly nausea, diarrhea, and vomiting. These affect a significant portion of people taking the drug, especially at higher doses. At the standard 10 mg daily dose, nausea occurs in about 19% of patients, diarrhea in 15%, and vomiting in 8%. Beyond gut symptoms, donepezil also carries a meaningful risk of slowing the heart rate, which can lead to fainting episodes.
Gastrointestinal Side Effects by Dose
Donepezil works by boosting levels of a chemical messenger in the brain called acetylcholine, which helps with memory and thinking. The problem is that acetylcholine also acts throughout the body, including the digestive system, where it increases muscle contractions and acid production. That’s why stomach and bowel issues are the most common complaints.
The difference between the 5 mg and 10 mg dose is striking. At 5 mg per day, about 5% of patients in clinical trials experienced nausea. At 10 mg, that number jumped to 19%, nearly quadrupling. Diarrhea went from 8% to 15%, and vomiting from 3% to 8%. These side effects tend to be worst in the first few weeks after starting the drug or increasing the dose, and they often fade with time. Prescribers typically start patients at 5 mg and keep them there for at least four weeks before moving to a higher dose, giving the body time to adjust. Some people need an even longer transition period.
Because donepezil increases stomach acid production, it also raises the risk of peptic ulcers and gastrointestinal bleeding. This is a particular concern for people who have a history of ulcers or who take anti-inflammatory painkillers like ibuprofen or naproxen at the same time.
Heart Rate and Fainting Risk
Donepezil can slow the heart by stimulating the vagus nerve, which acts as the body’s natural brake on heart rate. A meta-analysis covering over 97,000 patients found that the overall risk of an abnormally slow heart rate (bradycardia) was about 4.6%, and the risk of fainting (syncope) was about 2.3%. Compared to people not taking the drug, users had a 23% higher relative risk of bradycardia and a 40% higher relative risk of fainting.
This is why heart rate monitoring is a standard part of donepezil treatment. UK pharmacy guidelines call for checking a patient’s pulse before starting the drug, monthly after each dose change, and every six months once the dose is stable. Some patients, particularly those already at risk for heart rhythm problems, may also get an electrocardiogram (ECG) at baseline. Electrolyte levels are checked before starting treatment because imbalances in potassium or magnesium can make heart rhythm issues worse.
Weight Loss
Significant weight loss is an underappreciated side effect. A study tracking patients over 12 months found that about 29% of people taking cholinesterase inhibitors like donepezil lost 10 pounds or more, compared to roughly 23% of people not on these drugs. A 10-pound loss is enough to be clinically concerning, especially in older adults who may already be frail or eating poorly. Weight is typically recorded before treatment starts and monitored periodically afterward.
Breathing Difficulties in Lung Disease
The same mechanism that slows the heart can also tighten the airways. Acetylcholine causes the smooth muscles around the airways to contract, which is normally not a problem for healthy lungs. For someone with asthma or chronic obstructive pulmonary disease (COPD), though, this added constriction can worsen breathing. The FDA label specifically notes that donepezil should be prescribed with care in these patients.
Rare but Serious Reactions
Two rare conditions have been linked to donepezil: rhabdomyolysis and neuroleptic malignant syndrome (NMS). Rhabdomyolysis is a breakdown of muscle tissue that releases proteins into the bloodstream, potentially causing kidney failure and dangerous heart rhythms. Symptoms include muscle pain, weakness, fever, nausea, and dark-colored urine. A Health Canada safety review identified 88 international cases of rhabdomyolysis associated with donepezil, three of which were fatal.
NMS is a life-threatening condition involving high fever, severe muscle rigidity, mental confusion, and cardiovascular instability. The same review found 67 international cases linked to donepezil, with nine deaths. Both conditions are extremely rare relative to the millions of prescriptions written, but they require immediate medical attention if symptoms appear.
Why Side Effects Are Dose-Dependent
Nearly all of donepezil’s side effects trace back to the same root cause: too much acetylcholine activity outside the brain. The drug can’t selectively target the brain, so it amplifies acetylcholine signaling everywhere, in the gut, the heart, the lungs, and the muscles. Higher doses mean more acetylcholine activity, which is why the jump from 5 mg to 10 mg produces such a noticeable increase in side effects. The slow titration approach, holding at a lower dose for at least four weeks before increasing, is the primary strategy for keeping these effects manageable. For many patients, the gastrointestinal symptoms that dominate the first few weeks do eventually settle down, though heart rate effects require ongoing monitoring regardless of how long someone has been on the medication.